Osimertinib (AZD9291) Enhanced the Efficacy of Chemotherapeutic Agents in ABCB1- and ABCG2-Overexpressing Cells In Vitro, In Vivo, and Ex Vivo-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Osimertinib (AZD9291) Enhanced the Efficacy of Chemotherapeutic Agents in ABCB1- and ABCG2-Overexpressing Cells In Vitro, In Vivo, and Ex Vivo

Published:2016-05-18 Issue:8 Volume:15 Page:1845-1858
ISSN:1535-7163
Container-title:Molecular Cancer Therapeutics
language:en
Short-container-title:Mol Cancer Ther

Author:

Chen Zhen,Chen Yifan,Xu Meng,Chen Likun,Zhang Xu,To Kenneth Kin Wah,Zhao Hongyun,Wang Fang,Xia Zhongjun,Chen Xiaoqin,Fu Liwu

Funder

Natural Science Foundation of China

Ministry of Education of China

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phenylspirodrimane with Moderate Reversal Effect of Multidrug Resistance Isolated from the Deep-Sea Fungus Stachybotrys sp. 3A00409;Molecules;2024-04-08

2. High-dose short-term osimertinib treatment is effective in patient-derived metastatic colorectal cancer organoids;BJC Reports;2024-04-03

3. Epidermal Growth Factor Receptor Inhibitor Mobocertinib Resensitizes Multidrug-Resistant Cancer Cells by Attenuating the Human ATP-Binding Cassette Subfamily B Member 1 and Subfamily G Member 2;ACS Pharmacology & Translational Science;2023-12-05

4. Perspectives on drug repurposing to overcome cancer multidrug resistance mediated by ABCB1 and ABCG2;Drug Resistance Updates;2023-11

5. Furmonertinib, a Third-Generation EGFR Tyrosine Kinase Inhibitor, Overcomes Multidrug Resistance through Inhibiting ABCB1 and ABCG2 in Cancer Cells;International Journal of Molecular Sciences;2023-09-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3